Abstract
In the initial “National Heart, Lung, Blood, Institute Percutaneous Transluminal Coronary Angioplasty Registry” publication, which describes the immediate results of patients treated with angioplasty, major adverse cardiac events — i.e. death, myocardial infarction, coronary artery bypass grafting, repeat dilatation, — were reported in 13.6% of patients [1]. Due to an increase in operator experience and improvement in radiographic equipment and balloon catheter design over the succeeding 5 years, this number dropped to 4 to 7%, despite extension of the indications for coronary balloon angioplasty to include patients older than 70 years, and those with multivessel disease or with poor left ventricular function, prior bypass surgery and more severe and complex lesions [2, 3].
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Cowley MJ, Dorros G, Kelsey SF, Van Raden M, Detre KM. Acute coronary events associated with percutaneous transluminal coronary angioplasty. Am J Cardiol 1983; 53: 12C - 16C.
Detre KM, Holmes JS Jr, Holubkov R, et al. Incidence and consequences of periprocedural occlusion. The 1985–1986 National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Circulation 1990; 82: 739–750.
De Feyter PJ, van den Brand M, Laarman GJ, van Domburg R, Serruys PW, Suryapranata H. Acute Coronary Artery Occlusion During and After Percutaneous Transluminal Coronary Angioplasty. Frequency, Prediction, Clinical Course, Management, and Follow-up. Circulation 1991; 83: 927–936.
Hermans WRM, Rensing BJ, Foley DP et al. Therapeutic dissection after successful coronary angioplasty: no influence on restenosis or on clinical outcome: a study in 693 patients. J Am Coll Cardiol 1992; 20: 767–780.
Leimgruber PP, Roubin GS, Anderson HV, et al. Influence of intimal dissection on restenosis after successful coronary angioplasty. Circulation 1985; 72: 3: 530–535.
Matthews BJ, Ewels CJ, Kent KM. Coronary dissection: a predictor of restenosis ? Am Heart J 1988; 115: 547–554.
Huber MS, Mooney JF, Madison J, Mooney MR. Use of a morphologic classification to predict clinical outcome after dissection from coronary angioplasty. Am J Cardiol 1991; 68: 467–471.
Reiber JHC, Serruys PW. Quantitative coronary angiography. In: Marcus ML, Schelbert HR, Skorton DJ, Wolf GL (editors) Cardiac Imaging: A Companion to Braunwald’s Heart Disease. Philadelphia: WB Saunders Co, 1990; 211–280.
Serruys PW, Rutsch W, Heyndrickx GR, et al. Prevention of restenosis after percutaneous transluminal coronary angioplasty with thromboxane A2 receptor blockade. A randomized, double blind, placebo controlled trial. Circulation 1991; 84: 1568–1580.
MERCATOR study group. Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty ?. The results of the MERCATOR-study: a multicenter randomized double-blind placebo-controlled trial. Circulation 1992; 86: 100–110.
Hermans WRM, Foley DP, Rensing BJ et al. Usefulness of quantitative and qualitative angiographic lesion morphology and clinical characteristics in predicting major adverse cardiac events during and after native coronary balloon angioplasty. Am J Cardiol 1993; in press.
Campeau L. Grading of angina pectoris. Circulation 1976; 54: 522–523.
Austen WG, Edwards JE, Frye RL, et al. A reporting system in patients evaluated for grading of coronary artery disease. Report of the Ad Hoc Committee for Grading Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation 1975; 51: 7–40.
Ambrose JA, Winters SL, Stern A, et al. Angiographic morphology and the pathogenesis of unstable angina pectoris. J Am Coll Cardiol 1985: 5: 609–616.
Ellis SG, Roubin GS, King SB III, Douglas JS Jr, Cox WR. Importance of stenosis morphology in the estimation of restenosis after successful coronary angioplasty. Am J Cardiol 1989; 63: 30–34.
Mabin TA, Holmes DR Jr, Smith HC, et al. Intracoronary thrombus: Role in coronary occlusion complicating percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1985; 5: 198–202.
Ryan TJ, Faxon DP, Gunnar RM, et al. ACC/AHA Task Force Report: Guidelines for percutaneous transluminal coronary angioplasty. A report of College/American Heart Association Task Force on assessment of diagnostic and therapeutic cardiovascular procedures (subcommittee on percutaneous transluminal coronary angioplasty). J Am Coll Cardiol 1988; 12: 529–545.
Dorms G, Cowley MJ, Simpson J, et al. Percutaneous transluminal coronary angioplasty: Report of complications from the National Heart, Lung, and Blood Institute PTCA Registry. Circulation 1983; 67: 4: 723–730.
Guiteras Val PG, Bourassa MG, David PR, et al. Restenosis after successful percutaneous transluminal coronary angioplasty: The Montreal Heart Institute Experience. Am J Cardiol 1987; 10: 50B - 55B.
Hermans WRM, Rensing BJ, Kelder JC, de Feyter PJ, Serruys PW. Postangioplasty restenosis rate between segments of the major coronary arteries. Am J Cardiol 1992; 69: 194200.
Kuntz RE, Safian RD, Levine MJ, Reis GJ, Diver DJ, Baim DS. Novel approach to the analysis of restenosis after the use of three new coronary devices. J Am Coll Cardiol 1992; 19: 1493–1499.
Serruys PW, Foley DP, de Feyter PJ. Angiographic assessment of restenosis after coronary angioplasty and other devices: is it time for new comparative approaches based on quantitative angiography ? (editorial) Br Heart J; in press.
Ellis SG, Roubin GS, King SB III, et al. Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty. Circulation 1988; 77: 372–379.
Fuster V, Badimon L, Cohen M, Ambrose JA, Badimon JJ, Chesebro JH. Insights into the pathogenesis of acute ischemic syndromes. Circulation 1988; 77: 1213–1220.
Black AJR, Namay DL, Niederman AL, et al. Tear or Dissection After Coronary Angioplasty. Morphologic Correlates of an Ischemic Complication. Circulation 1989; 79: 1035–1042.
Myler RK, Shaw RE, Stertzer SH, et al. Lesion morphology and coronary angioplasty: current experience and analysis. J Am Coll Cardiol 1992; 19: 1641–1652.
Beatt KJ, Serruys PW, Hugenholtz PG. Restenosis after coronary angioplasty: New standards for clinical studies (editorial). J Am Coll Cardiol 1990; 15: 491–498.
Gould KL, Lipscombe K. Effects of coronary stenoses on coronary flow reserve and resistance. Am J Cardiol 1974; 33: 87–94.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Hermans, W.R.M., Foley, D.P., Rensing, B.J. (1994). The importance of coronary dissection during and after coronary balloon angioplasty as evaluated by quantitative coronary angiography. In: Serruys, P.W., Foley, D.P., De Feyter, P.J. (eds) Quantitative Coronary Angiography in Clinical Practice. Developments in Cardiovascular Medicine, vol 145. Springer, Dordrecht. https://doi.org/10.1007/978-94-015-8358-9_25
Download citation
DOI: https://doi.org/10.1007/978-94-015-8358-9_25
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-4295-8
Online ISBN: 978-94-015-8358-9
eBook Packages: Springer Book Archive